no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT
|
Gupta, Vipin |
|
2016 |
11 |
2 |
p. 181-187 |
article |
2 |
Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma
|
Kim, Hyung-Don |
|
2017 |
11 |
2 |
p. 209-219 |
article |
3 |
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
|
Sulkowski, Mark S. |
|
2017 |
11 |
2 |
p. 188-198 |
article |
4 |
Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
|
Papudesu, Chandana |
|
2016 |
11 |
2 |
p. 152-160 |
article |
5 |
Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
|
Machida, Keigo |
|
2016 |
11 |
2 |
p. 143-147 |
article |
6 |
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
|
Lin, Shi-Ming |
|
2016 |
11 |
2 |
p. 199-208 |
article |
7 |
Living donor liver transplant (LDLT) is the way forward in Asia
|
Rela, Mohamed |
|
2017 |
11 |
2 |
p. 148-151 |
article |
8 |
Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol
|
Steib, Christian J. |
|
2017 |
11 |
2 |
p. 141-142 |
article |
9 |
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
|
Lee, Rebecca |
|
2016 |
11 |
2 |
p. 161-170 |
article |
10 |
Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy
|
Lee, Rebecca |
|
|
11 |
2 |
p. 161-170 |
article |
11 |
Virus-induced hepatocellular carcinoma with special emphasis on HBV
|
Wang, Ming |
|
2017 |
11 |
2 |
p. 171-180 |
article |